Anti-TNFα therapy and vaccination of adults

Joint Bone Spine

Volumn 74, Issue 6, 2007, Pages 563-565

  Duchet Niedziolka, Paula ^a,b   Coutsinos, Zoé ^a,b   Hanslik, Thomas ^b,c   Launay, Odile ^a,b,d  

^a Institut Cochin   (France)

^b INSERM   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Guidelines; Immunizations; Immunodeficiency; TNF antagonists; Vaccination; Vaccines

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ADULT DISEASE; ANKYLOSING SPONDYLITIS; CHICKENPOX; CHRONIC ARTHRITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; HUMAN; INFECTION; INFLUENZA; INFLUENZA VACCINATION; MEASLES; MUMPS; PNEUMONIA; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RUBELLA; SEPSIS; SHORT SURVEY; STREPTOCOCCUS INFECTION; TREATMENT CONTRAINDICATION; VACCINATION; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; IMMUNOLOGY; METHODOLOGY; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; HUMANS; INFLUENZA VACCINES; OPPORTUNISTIC INFECTIONS; PNEUMOCOCCAL VACCINES; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES;

EID: 36949012704     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.08.001     Document Type: Short Survey

References (25)

1. Botsios C. Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases. Autoimmun Rev 4 (2005) 162-170
2. Kollias G., and Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 13 (2002) 315-321
3. Salliot C., Gossec L., Ruyssen-Witrand A., Luc M., Duclos M., Guignard S., et al. Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Rheumatology (Oxford) 46 (2007) 327-334
4. Crum N.F., Lederman E.R., and Wallace M.R. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore) 84 (2005) 291-302
5. Ritz M.A., and Jost R. Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. Inflamm Bowel Dis 7 (2001) 327
6. Baghai M., Osmon D.R., Wolk D.M., Wold L.E., Haidukewych G.J., and Matteson E.L. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 76 (2001) 653-656
7. Seo S.H., and Webster R.G. Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 76 (2002) 1071-1076
8. Vonkeman H., ten Napel C., Rasker H., and van de Laar M. Disseminated primary varicella infection during infliximab treatment. J Rheumatol 31 (2004) 2517-2518
9. Hanslik T., Boulard J.C., and Baglin A. Vaccination et maladies immunologiques. Rev Med Interne 17 (1996) 17-20
10. Wraith D.C., Goldman M., and Lambert P.H. Vaccination and autoimmune disease: what is the evidence?. Lancet 362 (2003) 1659-1666
11. Kengsakul K., Sathirapongsasuti K., and Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in case with HIV infection. J Med Assoc Thai 85 (2002) 131-134
12. Schrauder A., Henke-Gendo C., Seidemann K., Sasse M., Cario G., Moericke A., et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 369 (2007) 1232
13. Fomin I., Caspi D., Levy V., Varsano N., Shalev Y., Paran D., et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis 65 (2006) 191-194
14. Kapetanovic M.C., Saxne T., Nilsson J.A., and Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46 (2007) 608-611
15. Kaine J.L., Kivitz A.J., Birbara C., and Luo A.Y. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34 (2007) 272-279
16. Elkayam O., Caspi D., Reitblatt T., Charboneau D., and Rubins J.B. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33 (2004) 283-288
17. Visvanathan S., Keenan G.F., Baker D.G., Levinson A.I., and Wagner C.L. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34 (2007) 952-957
18. Mease P.J., Ritchlin C.T., Martin R.W., Gottlieb A.B., Baumgartner S.W., Burge D.J., et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31 (2004) 1356-1361
19. Kapetanovic M.C., Saxne T., Sjöholm A., Truedsson L., Jönsson G., and Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45 (2006) 106-111
20. Pham T., Claudepierre P., Deprez X., Fautrel B., Goupille P., Hilliquin P., et al., Club Rhumatismes et Inflammation, French Society of Rheumatology. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR). Joint Bone Spine 72 Suppl. 1 (2005) S1-S58
21. British Society for Rheumatology (BSR). Vaccinations in the immunocompromised person: guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies (2002), BSR.
22. Comité Technique des Vaccinations. Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France. Calendrier vaccinal 2006. BEH 29-30 (2006) 211-226
23. Ledingham J., Deighton C., British Society for Rheumatology Standards, and Guidelines and Audit Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44 (2005) 157-163 Erratum in
24. Ledingham J., Deighton C., British Society for Rheumatology Standards, and Guidelines and Audit Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 45 (2006) 1170
25. Ruef C. Immunization for hospital staff. Curr Opin Infect Dis 17 (2004) 335-339